# A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors

Source: https://onco.cc/trials/nct06929663/  
OnCo record `nct06929663` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

An early trial studying the safety and activity of experimental treatment. Its registry status does not establish patient benefit.

## Summary

A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors. ClinicalTrials.gov record last updated 2025-07-17: recruiting. Enrollment is planned at 48 participants. Primary completion is estimated at 2026-11-05. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-06
- Registry id: NCT06929663
- Phase: 1
- Setting: A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors
- Sponsor: Akeso

## Notes

- ClinicalTrials.gov record last updated 2025-07-17: recruiting. Enrollment is planned at 48 participants. Primary completion is estimated at 2026-11-05. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Sources

- ClinicalTrials.gov NCT06929663: https://clinicaltrials.gov/study/NCT06929663

## Connected records

- targets: [TROP2](https://onco.cc/targets/trop2/)
- drugs: [AK146D1](https://onco.cc/drugs/ak146d1/)

---
JSON: https://onco.cc/api/v1/entities/nct06929663.json